Schizoaffective disorder Trials in Atlanta, United States
Conditions / Schizoaffective disorder / Atlanta, United States
Schizoaffective disorder has been the subject of sustained clinical investigation across multiple research sites.
14 total trials for this combination
Showing top 10 of 14 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT00641745 | Lurasidone HCl - A Long Term Safety Phase 3 Study of Patients With Clinically Stable Schizophrenia | COMPLETED | PHASE3 |
| NCT01321177 | An Integrated Program for the Treatment of First Episode of Psychosis | COMPLETED | NA |
| NCT00303602 | Comparing the Effect of Under the Tongue Olanzapine Versus Swallowed Olanzapine on Body Mass Index (A Ratio of Weight to Height) | COMPLETED | PHASE4 |
| NCT01143077 | A Study Evaluating Lurasidone for The Treatment of Schizophrenia or Schizoaffective Disorder in Subjects Switched From Other Antipsychotic Agents | COMPLETED | PHASE3 |
| NCT05859698 | Study of the Effectiveness of Valbenazine on Patient- and Clinician-Reported Outcomes in Participants With Tardive Dyskinesia | COMPLETED | PHASE4 |
| NCT00206102 | A Study of the Cataractogenic Potential of Seroquel and Risperdal in the Treatment of Participants With Schizophrenia or Schizoaffective Disorder | COMPLETED | PHASE4 |
| NCT01143090 | A Study of Subjects Switched to Lurasidone for the Treatment of Schizophrenia or Schizoaffective Disorder | COMPLETED | PHASE3 |
| NCT00734435 | Olanzapine Given in Combination With Zonisamide SR to Prevent Weight Gain in Schizophrenic Subjects | TERMINATED | PHASE2 |
| NCT02091388 | Bioavailability of LY03004 and Risperdal® Consta® | COMPLETED | PHASE1 |
| NCT00423878 | Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective Disorder | COMPLETED | PHASE4 |